{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T23:38:07Z","timestamp":1778283487259,"version":"3.51.4"},"reference-count":48,"publisher":"Hindawi Limited","issue":"5","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":416,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Dermatol Ther"],"published-print":{"date-parts":[[2014,9]]},"DOI":"10.1111\/dth.12143","type":"journal-article","created":{"date-parts":[[2014,7,15]],"date-time":"2014-07-15T14:27:23Z","timestamp":1405434443000},"page":"298-303","source":"Crossref","is-referenced-by-count":14,"title":["Vitiligo nonsurgical treatment: a review of latest treatment researches"],"prefix":"10.1155","volume":"27","author":[{"given":"Yanfei","family":"Zhang","sequence":"first","affiliation":[{"name":"Department of Dermatology, The Second Affiliated Hospital, College of Medicine; Xi'an Jiaotong University; Xi'an Shaanxi Province China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jessini Soranambal","family":"Mooneyan-Ramchurn","sequence":"additional","affiliation":[{"name":"Department of Dermatology, The Second Affiliated Hospital, College of Medicine; Xi'an Jiaotong University; Xi'an Shaanxi Province China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nan","family":"Zuo","sequence":"additional","affiliation":[{"name":"Department of Dermatology, The Second Affiliated Hospital, College of Medicine; Xi'an Jiaotong University; Xi'an Shaanxi Province China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yiguo","family":"Feng","sequence":"additional","affiliation":[{"name":"Department of Dermatology, The Second Affiliated Hospital, College of Medicine; Xi'an Jiaotong University; Xi'an Shaanxi Province China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shengxiang","family":"Xiao","sequence":"additional","affiliation":[{"name":"Department of Dermatology, The Second Affiliated Hospital, College of Medicine; Xi'an Jiaotong University; Xi'an Shaanxi Province China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"98","published-online":{"date-parts":[[2014,7,12]]},"reference":[{"key":"10.1111\/dth.12143-BIB0001|dth12143-cit-0001","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/jid.1959.49","article-title":"Vitiligo","volume":"32","author":"Lerner","year":"1959","journal-title":"J Invest Dermatol"},{"key":"10.1111\/dth.12143-BIB0002|dth12143-cit-0002","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1016\/S0190-9622(87)70119-4","article-title":"Childhood vitiligo","volume":"16","author":"Halder","year":"1987","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/dth.12143-BIB0003|dth12143-cit-0003","doi-asserted-by":"crossref","first-page":"167","DOI":"10.2165\/00128071-200102030-00006","article-title":"Vitiligo. Pathogenesis and treatment","volume":"2","author":"Njoo","year":"2001","journal-title":"Am J Clin Dermatol"},{"issue":"3","key":"10.1111\/dth.12143-BIB0004|dth12143-cit-0004","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.jaad.2009.03.022","article-title":"The burden of vitiligo: patient characteristics associated with quality of life","volume":"61","author":"Linthorst Homan","year":"2009","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"10.1111\/dth.12143-BIB0005|dth12143-cit-0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1468-3083.2005.01369.x","article-title":"Psychosocial effects of vitiligo","volume":"20","author":"Ongenae","year":"2006","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"6","key":"10.1111\/dth.12143-BIB0006|dth12143-cit-0006","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1111\/j.1346-8138.2009.00646.x","article-title":"Quality of life for Korean patients with vitiligo: skindex-29 and its correlation with clinical profiles","volume":"36","author":"Kim do","year":"2009","journal-title":"J Dermatol"},{"key":"10.1111\/dth.12143-BIB0007|dth12143-cit-0007","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1111\/j.1365-4362.1996.tb03628.x","article-title":"Disability and handicap in dermatology","volume":"35","author":"Finlay","year":"1996","journal-title":"Int J Dermatol"},{"key":"10.1111\/dth.12143-BIB0008|dth12143-cit-0008","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1111\/phpp.12016","article-title":"Evaluation of serum 25-hy-droxyvitamin D levels in vitiligo patients with and without autoimmune diseases","volume":"29","author":"Saleh","year":"2013","journal-title":"Photodermatol Photoimmunol Photomed"},{"issue":"1","key":"10.1111\/dth.12143-BIB0009|dth12143-cit-0009","doi-asserted-by":"crossref","first-page":"222","DOI":"10.4161\/derm.24808","article-title":"A pilot study assessing the effect of prolonged administration of high daily doses of vitamin D on the clinical course of vitiligo and psoriasis","volume":"5","author":"Finamor","year":"2013","journal-title":"Dermatoendocrinol"},{"issue":"8","key":"10.1111\/dth.12143-BIB0010|dth12143-cit-0010","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1111\/j.1365-4632.2006.02744.x","article-title":"Increased tumor necrosis factor alpha (TNF-alpha) and interleukin 1 alpha (IL1-alpha) levels in the lesional skin of patients with nonsegmental vitiligo","volume":"45","author":"Birol","year":"2006","journal-title":"Int J Dermatol"},{"issue":"4","key":"10.1111\/dth.12143-BIB0011|dth12143-cit-0011","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.jsps.2012.12.003","article-title":"Methotrexate for the treatment of generalized vitiligo","volume":"21","author":"Alghamdi","year":"2013","journal-title":"Saudi Pharm J"},{"issue":"4","key":"10.1111\/dth.12143-BIB0012|dth12143-cit-0012","first-page":"761","article-title":"Efficacy of levamisole for the treatment of slow spreading vitiligo","volume":"22","author":"Khondker","year":"2013","journal-title":"Mymensingh Med J"},{"issue":"4","key":"10.1111\/dth.12143-BIB0013|dth12143-cit-0013","doi-asserted-by":"crossref","first-page":"259","DOI":"10.2310\/7750.2013.12053","article-title":"Low-dose oral mini-pulse dexamethasone therapy in progressive unstable vitiligo","volume":"17","author":"Kanwar","year":"2013","journal-title":"J Cutan Med Surg"},{"issue":"2","key":"10.1111\/dth.12143-BIB0014|dth12143-cit-0014","first-page":"159","article-title":"Failure of alefacept in the treatment of vitiligo","volume":"12","author":"Bin Dayel","year":"2013","journal-title":"J Drugs Dermatol"},{"key":"10.1111\/dth.12143-BIB0015|dth12143-cit-0015","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1111\/j.1365-2133.2008.08881.x","article-title":"Guideline for the diagnosis and management of vitiligo","volume":"159","author":"Gawkrodger","year":"2008","journal-title":"Br J Dermatol"},{"key":"10.1111\/dth.12143-BIB0016|dth12143-cit-0016","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.jaad.2008.06.023","article-title":"Therapeutic interventions for vitiligo","volume":"59","author":"Whitton","year":"2008","journal-title":"J Am Acad Dermatol"},{"issue":"11","key":"10.1111\/dth.12143-BIB0017|dth12143-cit-0017","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1111\/j.1468-3083.2008.02839.x","article-title":"A double-blind, randomized trial of 0.05% betamethasone vs. topical catalase\/dismutase superoxide in vitiligo","volume":"22","author":"Sanclemente","year":"2008","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"2","key":"10.1111\/dth.12143-BIB0018|dth12143-cit-0018","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1111\/j.1468-3083.2006.01413.x","article-title":"Psoralen-ultraviolet A vs. narrow-band ultraviolet B phototherapy for the treatment of vitiligo","volume":"20","author":"Parsad","year":"2006","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"4","key":"10.1111\/dth.12143-BIB0019|dth12143-cit-0019","first-page":"e63","article-title":"The therapeutic effects of a topical tretinoin and corticosteroid combination for vitiligo: a placebo-controlled, paired-comparison, left-right study","volume":"12","author":"Kwon","year":"2013","journal-title":"J Drugs Dermatol"},{"issue":"11","key":"10.1111\/dth.12143-BIB0020|dth12143-cit-0020","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1111\/1346-8138.12283","article-title":"Long-term efficacy and safety of tacrolimus ointment in the treatment of vitiligo","volume":"40","author":"Du","year":"2013","journal-title":"J Dermatol"},{"key":"10.1111\/dth.12143-BIB0021|dth12143-cit-0021","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1111\/j.1346-8138.2008.00511.x","article-title":"Topical immunomodulators are effective for treatment of vitiligo","volume":"35","author":"Choi","year":"2008","journal-title":"J Dermatol"},{"issue":"2","key":"10.1111\/dth.12143-BIB0022|dth12143-cit-0022","doi-asserted-by":"crossref","first-page":"168","DOI":"10.5021\/ad.2013.25.2.168","article-title":"A pilot study of 1% pimecrolimus cream for the treatment of childhood segmental vitiligo","volume":"25","author":"Shim","year":"2013","journal-title":"Ann Dermatol"},{"issue":"4","key":"10.1111\/dth.12143-BIB0023|dth12143-cit-0023","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1111\/j.1365-4632.2012.05697.x","article-title":"Efficacy of topical calcineurin inhibitors in vitiligo","volume":"52","author":"Wong","year":"2013","journal-title":"Int J Dermatol"},{"issue":"6","key":"10.1111\/dth.12143-BIB0024|dth12143-cit-0024","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1111\/j.1365-2133.2010.09692.x","article-title":"1,24-Dihydroxyvitamin D3 (tacalcitol) prevents skin T-cell infiltration","volume":"162","author":"Yamanaka","year":"2010","journal-title":"Br J Dermatol"},{"key":"10.1111\/dth.12143-BIB0025|dth12143-cit-0025","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1111\/j.1755-148X.2008.00528.x","article-title":"Update on skin repigmentation therapies in vitiligo","volume":"22","author":"Falabella","year":"2008","journal-title":"Pigment Cell Melanoma Res"},{"key":"10.1111\/dth.12143-BIB0026|dth12143-cit-0026","first-page":"483","article-title":"[Long-term effects of PUVA therapy on Israeli patients with vitiligo]","volume":"145","author":"Vussuki","year":"2006","journal-title":"Harefuah"},{"issue":"12","key":"10.1111\/dth.12143-BIB0027|dth12143-cit-0027","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1001\/archderm.1997.03890480045006","article-title":"Treatment of vitiligo with UV-B radiation vs topical psoralen plus UV-A","volume":"133","author":"Westerhof","year":"1997","journal-title":"Arch Dermatol"},{"issue":"5","key":"10.1111\/dth.12143-BIB0028|dth12143-cit-0028","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1111\/j.1468-3083.2006.02035.x","article-title":"Comparison of systemic PUVA and NB-UVB in the treatment of vitiligo: an open prospective study","volume":"21","author":"Bhatnagar","year":"2007","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"3","key":"10.1111\/dth.12143-BIB0029|dth12143-cit-0029","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.jaad.2008.07.053","article-title":"Narrowband ultraviolet B phototherapy and 308-nm excimer laser in the treatment of vitiligo: a review","volume":"60","author":"Nicolaidou","year":"2009","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"10.1111\/dth.12143-BIB0030|dth12143-cit-0030","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1111\/j.1755-148X.2008.00528.x","article-title":"Update on skin repigmentation therapies in vitiligo","volume":"22","author":"Falabella","year":"2009","journal-title":"Pigment Cell Melanoma Res"},{"issue":"8","key":"10.1111\/dth.12143-BIB0031|dth12143-cit-0031","doi-asserted-by":"crossref","first-page":"e1029","DOI":"10.1111\/j.1365-2230.2009.03712.x","article-title":"Topical tacrolimus may enhance repigmentation with targeted narrowband ultraviolet B to treat vitiligo: a randomized, controlled study","volume":"34","author":"Klahan","year":"2009","journal-title":"Clin Exp Dermatol"},{"issue":"2","key":"10.1111\/dth.12143-BIB0032|dth12143-cit-0032","first-page":"130","article-title":"Combined excimer laser and topical tacrolimus for the treatment of vitiligo: a pilot study","volume":"30","author":"Kawalek","year":"2004","journal-title":"Dermatol Surg"},{"issue":"4","key":"10.1111\/dth.12143-BIB0033|dth12143-cit-0033","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1111\/j.1468-3083.2006.02016.x","article-title":"Combination of 308-nm xenon chloride excimer laser and topical calcipotriol in vitiligo","volume":"21","author":"Goldinger","year":"2007","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"3","key":"10.1111\/dth.12143-BIB0034|dth12143-cit-0034","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1111\/1523-1747.ep12480997","article-title":"Role of hair follicles in the repigmentation of vitiligo","volume":"97","author":"Cui","year":"1991","journal-title":"J Invest Dermatol"},{"issue":"8","key":"10.1111\/dth.12143-BIB0035|dth12143-cit-0035","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1111\/ced.12099","article-title":"Broadband ultraviolet A vs. psoralen ultraviolet A in the treatment of vitiligo: a randomized controlled trial","volume":"38","author":"El Mofty","year":"2013","journal-title":"Clin Exp Dermatol"},{"issue":"5","key":"10.1111\/dth.12143-BIB0036|dth12143-cit-0036","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1111\/phpp.12061","article-title":"BB-UVA vs. NB-UVB in the treatment of vitiligo: a randomized controlled clinical study (single blinded)","volume":"29","author":"El-Mofty","year":"2013","journal-title":"Photodermatol Photoimmunol Photomed"},{"key":"10.1111\/dth.12143-BIB0037|dth12143-cit-0037","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/1745-6215-15-51","article-title":"Feasibility, double-blind, randomised, placebo-controlled, multi-centre trial of hand-held NB-UVB phototherapy for the treatment of vitiligo at home (HI-Light trial: Home Intervention of Light therapy)","volume":"15","author":"Eleftheriadou","year":"2014","journal-title":"Trials"},{"issue":"6","key":"10.1111\/dth.12143-BIB0038|dth12143-cit-0038","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1111\/phpp.12072","article-title":"Psoralen-narrowband UVB phototherapy for the treatment of vitiligo in comparison to narrowband UVB alone","volume":"29","author":"Bansal","year":"2013","journal-title":"Photodermatol Photoimmunol Photomed"},{"issue":"1","key":"10.1111\/dth.12143-BIB0039|dth12143-cit-0039","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1001\/2013.jamadermatol.386","article-title":"The efficacy of afamelanotide and narrowband UV-B phototherapy for repigmentation of vitiligo","volume":"149","author":"Grimes","year":"2013","journal-title":"JAMA Dermatol"},{"key":"10.1111\/dth.12143-BIB0040|dth12143-cit-0040","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/phpp.12015","article-title":"Comparison of the 308-nm excimer laser with the 308-nm excimer lamp in the treatment of vitiligo - a randomized bilateral comparison study","volume":"29","author":"Shi","year":"2013","journal-title":"Photodermatol Photoimmunol Photomed"},{"issue":"6","key":"10.1111\/dth.12143-BIB0041|dth12143-cit-0041","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1111\/bjd.12571","article-title":"Q-switched laser depigmentation in vitiligo, most effective in active disease","volume":"169","author":"Komen","year":"2013","journal-title":"Br J Dermatol"},{"issue":"3","key":"10.1111\/dth.12143-BIB0042|dth12143-cit-0042","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1111\/jdv.12038","article-title":"Laser-assisted depigmentation for resistant vitiligo: a retrospective case series with long-term follow-up","volume":"28","author":"Boukari","year":"2014","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"2","key":"10.1111\/dth.12143-BIB0043|dth12143-cit-0043","doi-asserted-by":"crossref","first-page":"93","DOI":"10.4103\/0974-2077.112670","article-title":"Depigmentation therapy with Q-switched Nd: YAG laser in universal vitiligo","volume":"6","author":"Majid","year":"2013","journal-title":"J Cutan Aesthet Surg"},{"issue":"5","key":"10.1111\/dth.12143-BIB0044|dth12143-cit-0044","first-page":"248","article-title":"Vitiligo patients seeking depigmentation therapy: a case report and guidelines for psychological screening","volume":"91","author":"Grau","year":"2013","journal-title":"Cutis"},{"issue":"12","key":"10.1111\/dth.12143-BIB0045|dth12143-cit-0045","first-page":"36","article-title":"Successful treatment of extensive vitiligo with monobenzone","volume":"5","author":"Rordam","year":"2012","journal-title":"J Clin Aesthet Dermatol"},{"issue":"7","key":"10.1111\/dth.12143-BIB0046|dth12143-cit-0046","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1111\/exd.12184","article-title":"A mouse model of vitiligo induced by monobenzone","volume":"22","author":"Zhu","year":"2013","journal-title":"Exp Dermatol"},{"issue":"3","key":"10.1111\/dth.12143-BIB0047|dth12143-cit-0047","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.anndiagpath.2014.01.002","article-title":"Immunohistochemical expression of aberrant Notch-1 signaling in vitiligo: an implication for pathogenesis","volume":"18","author":"Seleit","year":"2014","journal-title":"Ann Diagn Pathol"},{"issue":"5","key":"10.1111\/dth.12143-BIB0048|dth12143-cit-0048","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1111\/bjd.12147","article-title":"Vitiligo Potential Repigmentation Index: a simple clinical score that might predict the ability of vitiligo lesions to repigment under therapy","volume":"168","author":"Benzekri","year":"2013","journal-title":"Br J Dermatol"}],"container-title":["Dermatologic Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fdth.12143","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/dth.12143\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,30]],"date-time":"2024-05-30T05:18:34Z","timestamp":1717046314000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/dth.12143"}},"subtitle":["Vitiligo nonsurgical treatment"],"short-title":[],"issued":{"date-parts":[[2014,7,12]]},"references-count":48,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2014,9]]}},"URL":"https:\/\/doi.org\/10.1111\/dth.12143","relation":{},"ISSN":["1396-0296"],"issn-type":[{"value":"1396-0296","type":"print"}],"subject":[],"published":{"date-parts":[[2014,7,12]]}}}